JPS5589225A - Inflammation preventing medicine composition - Google Patents

Inflammation preventing medicine composition

Info

Publication number
JPS5589225A
JPS5589225A JP16368279A JP16368279A JPS5589225A JP S5589225 A JPS5589225 A JP S5589225A JP 16368279 A JP16368279 A JP 16368279A JP 16368279 A JP16368279 A JP 16368279A JP S5589225 A JPS5589225 A JP S5589225A
Authority
JP
Japan
Prior art keywords
medicine composition
preventing medicine
inflammation preventing
inflammation
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP16368279A
Other languages
English (en)
Other versions
JPS6320209B2 (ja
Inventor
Gitsuchi Mikurosu
Erudesu Adorujiyan
Haidoman Giyunta
Ritsutsuman Getsutsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Natterman und Cie GmbH
Original Assignee
A Natterman und Cie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Natterman und Cie GmbH filed Critical A Natterman und Cie GmbH
Publication of JPS5589225A publication Critical patent/JPS5589225A/ja
Publication of JPS6320209B2 publication Critical patent/JPS6320209B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
JP16368279A 1978-12-27 1979-12-18 Inflammation preventing medicine composition Granted JPS5589225A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2856333A DE2856333C2 (de) 1978-12-27 1978-12-27 Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung

Publications (2)

Publication Number Publication Date
JPS5589225A true JPS5589225A (en) 1980-07-05
JPS6320209B2 JPS6320209B2 (ja) 1988-04-26

Family

ID=6058494

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16368279A Granted JPS5589225A (en) 1978-12-27 1979-12-18 Inflammation preventing medicine composition

Country Status (13)

Country Link
US (1) US4332795A (ja)
JP (1) JPS5589225A (ja)
AT (1) AT369654B (ja)
BE (1) BE880830A (ja)
CA (1) CA1133395A (ja)
CH (1) CH643739A5 (ja)
DE (1) DE2856333C2 (ja)
FR (1) FR2445146A1 (ja)
GB (1) GB2039738B (ja)
IT (1) IT1164550B (ja)
NL (1) NL7909244A (ja)
SE (1) SE448603B (ja)
ZA (1) ZA797008B (ja)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5946221A (ja) * 1982-04-12 1984-03-15 ボード、オブ、リージェンツ、ザ、ユニバーシティー、オブ、テキサス、システム 胃腸潰瘍病治療用医薬組成物
JPS60169421A (ja) * 1983-12-22 1985-09-02 ア−・ナツタ−マン・ウント・コンパニ−・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 胃腸病治療用薬剤およびその製造方法
JPS60169420A (ja) * 1983-12-22 1985-09-02 ア−・ナツタ−マン・ウント・コンパニ−・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング リウマチ治療剤
US8865187B2 (en) 2000-12-19 2014-10-21 The Board Of Regents Of The University Of Texas System Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
WO2016185816A1 (ja) * 2015-05-18 2016-11-24 不二製油グループ本社株式会社 ＩＬ－１β産生抑制作用を有する食品添加用組成物
US10179104B2 (en) 2011-09-29 2019-01-15 Plx Opco Inc. PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
DE2914789A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Injizierbare arzneimittel mit entzuendungshemmender wirkung
DE2952115C2 (de) * 1979-12-22 1982-05-06 A. Nattermann & Cie GmbH, 5000 Köln Rosmarinsäure-Phospholipid-Komplex
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
GB2119244A (en) * 1982-04-30 1983-11-16 Alza Corp Potassium replacement therapy
US4666893A (en) * 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
US5043329A (en) * 1987-02-17 1991-08-27 Board Of Regents, University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US4950656A (en) * 1987-02-17 1990-08-21 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US5260284A (en) * 1987-02-17 1993-11-09 Board Of Regents, The University Of Texas System Methods employing unique mixtures of polar and neutral lipids and sterol for lung surfactant replacement therapy
US4918063A (en) * 1987-02-17 1990-04-17 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5091187A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5763422A (en) * 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
KR100508910B1 (ko) * 1995-10-17 2006-04-20 알티피 파마 코포레이션 불용성약물방출
AUPN766496A0 (en) * 1996-01-22 1996-02-15 University Of New England, The Method and composition for the potentiation of anti-inflammatory drugs
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
CN1289091C (zh) * 1998-02-11 2006-12-13 Rtp药品公司 治疗炎症的药物组合物和相关用途
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
AU764001B2 (en) 1998-05-29 2003-08-07 Skyepharma Canada Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
DE69912441T2 (de) 1998-08-19 2004-08-19 Skyepharma Canada Inc., Verdun Injizierbare wässerige propofoldispersionen
PL201578B1 (pl) 1998-11-20 2009-04-30 Skyepharma Canada Inc Stała terapeutyczna postać dawkowania nierozpuszczalnego lub słabo rozpuszczalnego w wodzie związku
KR100801588B1 (ko) * 1999-09-21 2008-02-05 스키에파마 캐나다 인코포레이티드 생물학적 유효 물질의 표면 변형된 미립자 조성물
US6682761B2 (en) 2000-04-20 2004-01-27 Rtp Pharma, Inc. Water-insoluble drug particle process
DE60137943D1 (de) 2000-08-31 2009-04-23 Jagotec Ag Gemahlene partikel
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
CA2423336C (en) * 2000-09-20 2011-03-08 Rtp Pharma Inc. Stabilised fibrate microparticles
US20100173876A1 (en) * 2000-12-19 2010-07-08 The Board Of Regents Of The University Of Texas System Oil-based nsaid compositions and methods for making and using same
PL202778B1 (pl) * 2001-02-22 2009-07-31 Skyepharma Canada Inc Postać dawkowana kombinacji statyny i fenofibratu, sposób jej wytwarzania i zastosowanie
JP2023518822A (ja) 2020-03-26 2023-05-08 ピーエルエックス オプコ インコーポレイテッド ｐＨ依存的再構築が可能な医薬キャリア、その製造方法及び使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL32337C (ja) *
IT1044768B (it) * 1969-04-03 1980-04-21 Italeapmaco Spa Supposte contenenti un principio attivo ascorbato di aminofemazione liofilizzato e processo per la loro preparazione

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEM ABSTR *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5946221A (ja) * 1982-04-12 1984-03-15 ボード、オブ、リージェンツ、ザ、ユニバーシティー、オブ、テキサス、システム 胃腸潰瘍病治療用医薬組成物
JPH0569811B2 (ja) * 1982-04-12 1993-10-01 Uni Tekisasu Shisutemu Za
JPS60169421A (ja) * 1983-12-22 1985-09-02 ア−・ナツタ−マン・ウント・コンパニ−・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 胃腸病治療用薬剤およびその製造方法
JPS60169420A (ja) * 1983-12-22 1985-09-02 ア−・ナツタ−マン・ウント・コンパニ−・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング リウマチ治療剤
JPH0112729B2 (ja) * 1983-12-22 1989-03-02 Nattermann A & Cie
JPH0577653B2 (ja) * 1983-12-22 1993-10-27 Nattermann A & Cie
US8865187B2 (en) 2000-12-19 2014-10-21 The Board Of Regents Of The University Of Texas System Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
US8911752B2 (en) 2000-12-19 2014-12-16 The Board Of Regents Of The University Of Texas System Methods of making compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity
US9101637B2 (en) 2000-12-19 2015-08-11 The Board Of Regents Of The University Of Texas System Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity
US9687551B2 (en) 2000-12-19 2017-06-27 The Board Of Regents Of The University Of Texas System Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
US10179104B2 (en) 2011-09-29 2019-01-15 Plx Opco Inc. PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
US10646431B2 (en) 2011-09-29 2020-05-12 Plx Opco Inc. PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
US10786444B2 (en) 2011-09-29 2020-09-29 Plx Opco Inc. PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
WO2016185816A1 (ja) * 2015-05-18 2016-11-24 不二製油グループ本社株式会社 ＩＬ－１β産生抑制作用を有する食品添加用組成物
JP6103143B1 (ja) * 2015-05-18 2017-03-29 不二製油株式会社 ＩＬ−１β産生抑制作用を有する食品添加用組成物

Also Published As

Publication number Publication date
CH643739A5 (de) 1984-06-29
FR2445146A1 (fr) 1980-07-25
ZA797008B (en) 1980-12-31
CA1133395A (en) 1982-10-12
NL7909244A (nl) 1980-07-01
FR2445146B1 (ja) 1983-09-02
US4332795A (en) 1982-06-01
IT7928358A0 (it) 1979-12-21
SE448603B (sv) 1987-03-09
JPS6320209B2 (ja) 1988-04-26
GB2039738A (en) 1980-08-20
DE2856333C2 (de) 1983-09-22
DE2856333A1 (de) 1980-08-21
SE7910371L (sv) 1980-06-28
ATA808379A (de) 1982-06-15
IT1164550B (it) 1987-04-15
AT369654B (de) 1983-01-25
GB2039738B (en) 1983-04-13
BE880830A (fr) 1980-04-16

Similar Documents

Publication Publication Date Title
JPS5589225A (en) Inflammation preventing medicine composition
GB2085732B (en) Administration set
JPS54132223A (en) Novel pharmaceutical composition
NZ189378A (en) 4-amino-5-alkylsulphonyl-ortho-anisamdes and pharmaceutical compositions
NZ190784A (en) Benzofuranyl-piperidines and pharmaceutical compositions
JPS5579321A (en) Medical composition for local administration
JPS5598110A (en) Local administration composition
ZA787000B (en) Pharmaceutical formulation
JPS5555200A (en) Steroid compound and medicine composition
NZ189684A (en) Substituted 2-phenylimino-imidazolidines pharmaceutical compositions
IL56577A0 (en) Pharmaceutical compositions comprising certain pyrrolidinederivatives
JPS5594318A (en) Analgesic composition
JPS559074A (en) Compound and drug composition
JPS5579388A (en) Medical composition containing amoxicillin
ZA793923B (en) Medicinal formulation
GB2034587B (en) Pharmaceutical compositions
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
JPS54154516A (en) Pharmaceutical composition
GB2031727B (en) Pharmaceutical compositions
GB2039218B (en) Pharmaceutical compositions
NZ189279A (en) Arylaminoimidazolines and pharmaceutical compositions
JPS5527168A (en) Drug composition
NZ190293A (en) Benzimidoyl-piperazines and pharmaceutical compositions
JPS5540677A (en) Medical composition
ZA794484B (en) Pharmaceutical compositions